We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.97B
AUM Growth
+$660M
Cap. Flow
+$542M
Cap. Flow %
18.28%
Top 10 Hldgs %
31.64%
Holding
3,611
New
266
Increased
1,484
Reduced
936
Closed
189
Avg Time Held Equity + Options
3.4 years
Top 10 Avg Time Held Equity + Options
2 years
Top 20 Avg Time Held Equity + Options
2.3 years
Avg Time Held Equity only
3.5 years
Top 10 Avg Time Held Equity only
2 years
Top 20 Avg Time Held Equity only
2.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.73%
2 Technology 13.87%
3 Healthcare 8.82%
4 Financials 7.01%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MRUS icon
3326
DELISTED
Merus
MRUS
$110 ﹤0.01%
+6
New +$105
2023 Q1
0 quarters
BCYC icon
3327
Bicycle Therapeutics
BCYC
$249M
$106 ﹤0.01%
5
– –
2021 Q4
5 quarters
LZ icon
3328
LegalZoom.com
LZ
$1.05B
$103 ﹤0.01%
11
– –
2021 Q4
5 quarters
MNRO icon
3329
Monro
MNRO
$447M
$99 ﹤0.01%
2
– –
2022 Q3
2 quarters
UCTT icon
3330
Ultra Clean Holdings
UCTT
$2.5B
$99 ﹤0.01%
3
– –
2021 Q3
6 quarters
CWAN icon
3331
DELISTED
Clearwater Analytics
CWAN
$96 ﹤0.01%
6
-8
-57% -$140
2022 Q4
1 quarter
ALEC icon
3332
Alector
ALEC
$213M
$93 ﹤0.01%
15
– –
2021 Q1
8 quarters
NABL icon
3333
N-able
NABL
$871M
$92 ﹤0.01%
7
– –
2022 Q4
1 quarter
AKTS icon
3334
DELISTED
Akoustis Technologies Inc
AKTS
$92 ﹤0.01%
30
– –
2020 Q4
9 quarters
NAVB
3335
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$91 ﹤0.01%
350
– –
2020 Q1
12 quarters
GRWG icon
3336
GrowGeneration
GRWG
$87.8M
$89 ﹤0.01%
26
– –
2021 Q1
8 quarters
FFAI
3337
Faraday Future Intelligent Electric
FFAI
$5.1M
– –
0
– –
2021 Q3
6 quarters
PSDN
3338
DELISTED
AdvisorShares Poseidon Dynamic Cannabis ETF
PSDN
$88 ﹤0.01%
70
– –
2022 Q1
4 quarters
AUY
3339
DELISTED
Yamana Gold, Inc.
AUY
$88 ﹤0.01%
15
– –
2020 Q3
10 quarters
IRBT icon
3340
DELISTED
iRobot
IRBT
$87 ﹤0.01%
+2
New +$89
2023 Q1
0 quarters
YOLO icon
3341
AdvisorShares Pure Cannabis ETF
YOLO
$30.3M
$87 ﹤0.01%
+30
New +$104
2023 Q1
0 quarters
OGI icon
3342
Organigram Holdings
OGI
$135M
$83 ﹤0.01%
33
– –
2019 Q3
14 quarters
LASR icon
3343
nLIGHT
LASR
$2.06B
$81 ﹤0.01%
8
– –
2022 Q4
1 quarter
BALY icon
3344
Bally's
BALY
$681M
$78 ﹤0.01%
+4
New +$78
2023 Q1
0 quarters
DOO icon
3345
Bombardier Recreational Products
DOO
$3.95B
$78 ﹤0.01%
+1
New +$82
2023 Q1
0 quarters
LGND icon
3346
Ligand Pharmaceuticals
LGND
$5.97B
$74 ﹤0.01%
1
– –
2022 Q3
2 quarters
BW icon
3347
Babcock & Wilcox
BW
$727M
$73 ﹤0.01%
12
– –
2022 Q2
3 quarters
ZIMV icon
3348
DELISTED
ZimVie
ZIMV
$72 ﹤0.01%
10
-1
-9% -$9
2022 Q1
4 quarters
AVDX icon
3349
DELISTED
AvidXchange
AVDX
$70 ﹤0.01%
9
– –
2022 Q4
1 quarter
CCSI icon
3350
Consensus Cloud Solutions
CCSI
$673M
$68 ﹤0.01%
2
– –
2021 Q4
5 quarters

Similar funds

Parallel Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Parallel Advisors held 3,611 positions worth $2.97B, up 29% from $2.31B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parallel Advisors deployed $542M of net new capital in Q1 2023, opening 266 new positions and adding to 1,484 existing holdings. Its largest new stake was Vanguard International Dividend Appreciation ETF: 74,827 shares worth $5.51M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 54% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street Energy Select Sector SPDR ETF, an estimated $21.8M trimmed.

  • Parallel Advisors's largest Q1 2023 buy was Vanguard International Dividend Appreciation ETF: 74,827 shares worth $5.51M.
  • Parallel Advisors added most to iShares 0-1 Year Treasury Bond ETF in Q1 2023, an estimated $38.1M increase.
  • Parallel Advisors's biggest Q1 2023 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $21.8M.
  • Parallel Advisors fully exited 1Life Healthcare in Q1 2023, selling an estimated $1.96M.
  • Parallel Advisors's ten largest holdings make up 32% of its $2.97B portfolio in Q1 2023.
  • Parallel Advisors opened 266 new positions and closed 189 in Q1 2023.
  • Parallel Advisors's portfolio value rose 29% quarter-over-quarter to $2.97B.

Based on Parallel Advisors's 13F filing for Q1 2023, filed 25 Apr 2023.